Engineering an Antibody V Gene-Selective Vaccine

• Larance Ronsard,
• Ashraf S. Yousif,
• Julianne Peabody,
• Vintus Okonkwo,
• Pascal Devant,
• Alemu Tekewe Mogus,
• Ralston M. Barnes,
• Daniel Rohrer,
• Nils Lonberg,
• David Peabody,
• Bryce Chackerian,
• Daniel Lingwood

Affiliations

Larance Ronsard

The Ragon Institute of Massachusetts General Hospital, The Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States

Ashraf S. Yousif

The Ragon Institute of Massachusetts General Hospital, The Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States

Julianne Peabody

Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, United States

Vintus Okonkwo

The Ragon Institute of Massachusetts General Hospital, The Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States

Pascal Devant

The Ragon Institute of Massachusetts General Hospital, The Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States

Alemu Tekewe Mogus

Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, United States

Ralston M. Barnes

Bristol-Myers Squibb, Redwood City, CA, United States

Daniel Rohrer

Bristol-Myers Squibb, Redwood City, CA, United States

Nils Lonberg

Bristol-Myers Squibb, Redwood City, CA, United States

David Peabody

Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, United States

Bryce Chackerian

Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, United States

Daniel Lingwood

The Ragon Institute of Massachusetts General Hospital, The Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States